Not Yet Recruiting NA INTERVENTIONAL 4-arm NCT07043868

Effects and Feasibility of Photobiomodulation at 830nm Nanometers in the Treatment of Diabetic Ulcers

Effects and Feasibility of Photobiomodulation at 830 Nanometers in the Treatment of Diabetic Ulcers: a Randomized, Double-blind Clinical Trial

Sponsor: Federal University of Piaui

Conditions Diabete Type 2 Diabetic Foot Ulcer Low Level Laser Therapy Photobiomodulation

Interventions Low Level Laser Therapy

Updated 2 times since 2025 Last updated: Jul 5, 2025 Started: Jan 10, 2026 Primary completion: Jan 10, 2027 Completion: Jan 10, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Diabete Type 2 and Diabetic Foot Ulcer and is currently actively recruiting participants. Federal University of Piaui leads this study, which shows 2 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Aug 2025 — Present [monthly]

Not Yet Recruiting NA
Jul 2025 — Aug 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federal University of Piaui

Data source: Federal University of Piaui

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.